Leiv Lea, Corvus Pharmaceuticals, Inc.'s Chief Financial Officer, recently acquired 24,700 shares of the company. The buys took place at $4.15 per share, on December 21, 2018. Lea now owns 173,906 shares of the company. Lea operates out of Burlingame, CA. Some additional info was provided as follows:
The price reported in Column 4 is a weighted price. These Shares were purchased in multiple transactions at prices ranging from $4.13 to $4.17 inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the Shares purchased at each separate price within the range set forth in this footnote.
These shares are held by Leiv Lea IRA Contributory.
A portion of these shares is subject to a right of repurchase held by the Issuer.
These shares are held by Leiv Lea and Deborah Karlson, Trustees of the Karlson Lea Family Trust UTA dated February 11, 1998 (the "Karlson Lea Trust"). Mr. Lea has shared voting, investment and dispositive power over the shares held by the Karlson Lea Trust.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Corvus Pharmaceuticals, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
On September - Sept. 17, 2020
Corvus Pharmaceuticals, Inc. director was just granted 30,000 options - Sept. 15, 2020
Corvus Pharmaceuticals, Inc. director just declared 0 ownership of the company. - Sept. 15, 2020
Departure of Directors or Certain - Sept. 11, 2020
On September - Sept. 10, 2020